Drugs & medicalClass II

Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC…

cGMP Deviations

Read the official notice →
Date
2025-05-07
Country
United States
Brand
Preferred Pharmaceuticals
Product
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Classification
Class II
Units
Nationwide in the US
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Preferred Pharmaceuticals recalls

  1. 2026-10-14
  2. US
  3. 2026-04-15
  4. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg:…

    Lack of Assurance of Sterility

    FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice →
  5. 2025-12-24
  6. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred…

    Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished…

    FDA · DrugPreferred Pharmaceuticals, Inc.Natinowide in the USAOfficial notice →
  7. 2024-09-04
  8. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana,…

    Failed Impurities/Degradation Specifications - at 18-month Stability testing

    FDA · DrugPreferred Pharmaceuticals, Inc.CA and NVOfficial notice →
  9. 2024-05-29
  10. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

    FDA · DrugPreferred Pharmaceuticals, Inc.Product distributed to CA, FL, OK, KS and CTOfficial notice →
  11. 2023-07-12
  12. US
    Drugs & medicalClass II

    Preferred Pharmaceuticals, Inc. recalls Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3),…

    Failed Stability Specifications

    FDA · DrugPreferred Pharmaceuticals, Inc.Nationwide within the United StatesOfficial notice →
All 17 Preferred Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2025-05-07
  2. US
  3. US
    Drugs & medicalClass II

    Cardinal Health Inc. recalls Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose…

    Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically,…

    FDA · DrugCardinal Health Inc.NC, SC, VAOfficial notice →
  4. US
    Drugs & medicalClass II

    Nubratori, Inc recalls Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative…

    Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly…

    FDA · DrugNubratori, IncPA and CA.Official notice →
  5. US
    Drugs & medicalClass II

    Eugia US LLC recalls Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for:…

    Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

    FDA · DrugEugia US LLCUSA nationwide.Official notice →
  6. 2025-04-30
  7. US
    Drugs & medicalClass II

    Straumann USA LLC recalls WB XL Anatomic Healing Abutment XC. Endosseous Dental Implant Abutments.

    Incorrect blister labelling.

    FDA · DeviceStraumann USA LLCWorldwide distribution - US Nationwide and the countries of Belgium, Canada,…Official notice →
  8. US
    Drugs & medicalClass II

    Micro-X Ltd. recalls Brand Name: Rover Product Name: Mobile X-ray System Model/Catalog Number:MXU-RV35 Product Description: Rover Mobile X-rays System…

    Potential for internal fastening mechanism within generator of mobile x-Ray to fail.

    FDA · DeviceMicro-X Ltd.US: NJ, WA, Puerto Rico OUS: NoneOfficial notice →
See all drugs & medical recalls →